Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
02/2001
02/02/2001CA2314750A1 Process for the preparation of 3-substituted 4-phenyl-piperidine derivatives
02/01/2001WO2001007438A1 Enantioselective acylation of cis racemic azetidinones
02/01/2001WO2001007436A2 Substituted oxoazaheterocyclyl compounds
02/01/2001WO2001007434A2 Indole derivatives and their use as 5ht2a ligands
02/01/2001WO2001007409A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands
02/01/2001WO2001007408A2 Novel method for preparing benzoperhydroisoindole compounds
02/01/2001WO2001007043A1 Azetidine carboxamide derivatives for the treatment of cns disorders
02/01/2001WO2001007020A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
02/01/2001WO2000067735A3 USE OF SELECTIVE ANTAGONISTS OF THE α1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION
02/01/2001WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia
02/01/2001WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
02/01/2001DE19935219A1 Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung Carboxamides, medicaments containing these compounds, their use and production
02/01/2001DE19934432A1 Indolderivate Indole derivatives
02/01/2001CA2382755A1 Substituted oxoazaheterocyclyl compounds
02/01/2001CA2379859A1 Novel method for preparing benzoperhydroisoindole compounds
01/2001
01/31/2001EP1072601A2 4-arylpiperidine derivatives for the treatment of pruritus
01/31/2001EP1072597A1 Pyrazoles and their use as endothelin antagonists
01/31/2001EP1072595A2 4-arylpiperidine derivatives for the treatment of pruritus
01/31/2001EP1072594A2 4-arylpiperidine derivatives for the treatment of pruritus
01/31/2001EP1072593A1 Liquid crystalline compound having piperidine ring, liquid crystal composition and liquid crystal display element
01/31/2001EP1072263A1 Amide derivatives and nociceptin antagonists
01/31/2001EP1071681A1 Nitroxyl derivatives with glycidyl or alkylcarbonyl groups as initiators for radical polymerisation
01/31/2001EP1071680A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors
01/31/2001EP1071672A1 6-substituted 2,4-diamino-1,3,5-triazine derivatives having at least two asymmetrically substituted carbon atoms, the production thereof, and their use as herbicides
01/31/2001EP1071668A1 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents
01/31/2001EP1071666A1 Azacycloalkane derivatives, preparation and therapeutic application
01/31/2001CN1282326A Anilide derivative, production and use thereof
01/31/2001CN1282319A Aminobutanoic acid derivatives
01/31/2001CN1282251A Method and material for treating and preventing mucosal tissue inflammation
01/31/2001CN1281852A 三唑及咪唑衍生物 Triazole and imidazole derivatives
01/31/2001CN1061346C Diazabicycloalkene derivatives and use, and drug composition containing said derivatives
01/31/2001CN1061339C Novel sulfonamide inhibitors of aspartyl protease
01/30/2001US6180786 Antagonist for excitory amino acids
01/30/2001US6180656 Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems
01/30/2001US6180651 Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics
01/30/2001US6180650 Antiinflammatory agents; respiratory system disorders; skin disorders; antitumor agents
01/30/2001US6180645 Antiepilepic agent
01/30/2001US6180643 Antagonist of interleukins, tumor necrosis factor
01/30/2001US6180632 Use of these compounds for treating disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or t cell activation and proliferation
01/30/2001US6180628 Compounds, compositions and methods for treating influenza
01/30/2001US6180627 Antithrombotic agents
01/30/2001US6180567 Reacting 2-alkoxycarbonyl-benzenesulfonamide derivative with 1,2,4-(1h)triazole-5-(thi)one derivative
01/30/2001US6180087 Tunable indocyanine dyes for biomedical applications
01/30/2001US6180085 Useful for optical tomographic, endoscopic, photoacoustic and sonofluoresence applications for detection and treatment of tumors and other abnormalities
01/30/2001CA2191352C Quinoline derivatives as tachykinin nk3 receptor antagonists
01/25/2001WO2001005785A1 Substituted phenyl uracils
01/25/2001WO2001005784A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR Xa INHIBITORS
01/25/2001WO2001005783A1 Bradykinin b1 receptor antagonists
01/25/2001WO2001005782A1 Novel diphenyl-piperidine derivate
01/25/2001WO2001005774A1 Heteroaromatic ring compounds
01/25/2001WO2001005772A1 Pyrazinones, compositions containing such compounds
01/25/2001WO2001005771A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists
01/25/2001WO2001005770A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors
01/25/2001WO2001005769A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/25/2001WO2001005760A2 New process for the preparation of spiro [(4-cyclohexanone)-[3h]indol]-2'[1'h]-one derivatives
01/25/2001WO2001005758A2 Indoles and indazoles for the treatment of migraine
01/25/2001WO2001005398A1 Phosphate transport inhibitors
01/25/2001WO2001005230A1 Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof
01/25/2001DE19933164A1 Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten New carboxylic acid derivatives with 5,6-substituted pyrimidine ring, their preparation and use as endothelin receptor antagonists
01/25/2001CA2380727A1 Nitrogen containing heterobicycles as factor xa inhibitors
01/25/2001CA2379657A1 Phosphate transport inhibitors
01/25/2001CA2379554A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors
01/25/2001CA2379545A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists
01/25/2001CA2379064A1 Bradykinin b1 receptor antagonists
01/25/2001CA2378962A1 Substituted phenyl uracils
01/25/2001CA2378084A1 Novel diphenyl-piperidine derivate
01/25/2001CA2378047A1 Heterocyclic compounds for the treatment of migraine
01/25/2001CA2377527A1 Heteroaromatic ring compounds
01/25/2001CA2375954A1 Alpha-hydroxy-gamma-¬¬(carbocyclic-or heterocyclic-substituted)amino|carbonyl|alkanamide derivatives and uses thereof
01/24/2001EP1070715A1 Arylpiperidine derivatives and use thereof
01/24/2001EP1070712A1 Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof
01/24/2001EP1070708A1 Triazole and imidazole derivatives
01/24/2001EP1070705A1 Indole derivatives
01/24/2001EP1070076A1 Chiral separations of pyrimidines
01/24/2001EP1070063A1 Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)
01/24/2001EP1070062A1 Oxidation process using tempo
01/24/2001EP1070061A1 Oxidation process using periodic acid
01/24/2001EP1070058A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
01/24/2001EP1070055A1 Substituted phenyl pyridazinones
01/24/2001EP1070054A1 Amine compounds, their production and their use as somatostatin receptor antagonists or agonists
01/24/2001EP1070050A1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
01/24/2001EP1070041A1 Phosphate-mediated cyclization
01/24/2001EP0931080A4 Amorphous paroxetine composition
01/24/2001EP0788496B1 Apolipoprotein-b synthesis inhibitors
01/24/2001EP0610377B1 Tri-substituted tetrahydrofuran antifungals
01/24/2001CN1281450A Substituted 2,4-diamino-1,3,5-triazine and their use as herbicides
01/24/2001CN1281449A Crystalline antifungal polymorph
01/24/2001CN1281448A Process for preparation of paroxetine hydrochloride
01/24/2001CN1281447A (i(E))-3-[1-i(n)-butyl-5-[2-(-carboxyphenyl) methoxy-4-chlorophenyl]-1i(H)-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl) methyl]-prop-2-enoic acid monoargininyl salt
01/24/2001CN1281439A 4-Hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
01/24/2001CN1281433A Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors
01/24/2001CN1281362A Novel combination medicine
01/24/2001CN1281335A Treatment of schizophrenia with ampakines and neuroleptics
01/24/2001CN1281334A Method for treating Alzheimer's disease
01/24/2001CN1061036C Substituted pyrazolyl benzenesulfonamides for treating inflammation
01/23/2001USRE37029 Antipsychotic and analgesic agents
01/23/2001US6177459 Substituted heterocyclic compounds and their use as fungicides
01/23/2001US6177449 Cardiovascular disorders; antiulcer agents
01/23/2001US6177446 Synergistic
01/23/2001US6177432 Farnesyltransferase inhibiting quinazolinones